Treatment with N-acetyl-seryl-aspartyl-lysyl-proline prevents experimental autoimmune myocarditis in rats
about
The Effects of Angiotensin Converting Enzyme Inhibitors (ACE-I) on Human N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (Ac-SDKP) Levels: A Systematic Review and Meta-AnalysisN-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetesN-Acetyl-Seryl-Aspartyl-Lysyl-Proline: mechanisms of renal protection in mouse model of systemic lupus erythematosusAcetylated α-Tubulin Regulated by N-Acetyl-Seryl-Aspartyl-Lysyl-Proline(Ac-SDKP) Exerts the Anti-fibrotic Effect in Rat Lung Fibrosis Induced by SilicaRenal protective effect of N-acetyl-seryl-aspartyl-lysyl-proline in dahl salt-sensitive rats.The anti-inflammatory peptide Ac-SDKP is released from thymosin-β4 by renal meprin-α and prolyl oligopeptidase.Cannabidiol limits Tcell-mediated chronic autoimmune myocarditis: implications to autoimmune disorders and organ transplantation.Suppression of gelatinase activity in human peripheral blood mononuclear cells by verapamil.Effects of N-acetyl-seryl-asparyl-lysyl-proline on blood pressure, renal damage, and mortality in systemic lupus erythematosusAntifibrotic peptide N-acetyl-Ser-Asp-Lys-Pro (Ac-SDKP): opportunities for angiotensin-converting enzyme inhibitor design.Angiotensin-converting enzyme and the tumor microenvironment: mechanisms beyond angiogenesis.Intravital microscopy - A novel tool in characterizing congestive heart failure in experimental autoimmune myocarditis.Ac-SDKP suppresses TNF-α-induced ICAM-1 expression in endothelial cells via inhibition of IκB kinase and NF-κB activation.Cardiac-deleterious role of galectin-3 in chronic angiotensin II-induced hypertension.Periodontal bacteria aggravate experimental autoimmune myocarditis in mice.Ac-SDKP decreases mortality and cardiac rupture after acute myocardial infarction.
P2860
Q26776514-9C5A36A9-04A6-4A28-B1F7-E287CEA4E183Q27008887-5B2E0CA7-B2D0-405A-A93A-EB185F28779AQ35622459-3272237B-870F-463A-A445-8BF920128F03Q36117802-883CF8D6-938E-4DF0-8AD2-9C8022A1341EQ36315598-5C1D01DB-E028-48FA-8D61-F6433D68330FQ36957095-C484515D-CAF5-44EA-98F1-98147E11DBC5Q37217043-DC279BA0-647D-468F-BAEB-7A22ECA27186Q37600812-ACC5D270-448B-4AA3-8F62-AB2804B6AC40Q37609039-FE8D3C9F-0141-4972-94CC-5E8041116FACQ38076770-EB9FEBB0-892F-4721-99E7-861462B8480CQ38112273-4F5E736B-D76C-4A28-9945-F2ABC0D34764Q41200031-F68FA6F9-4F69-4AAB-A14B-D161C0F35A0BQ42329928-B00F687D-6454-4791-B41C-AED94FBC3A97Q42784122-1E24B6F9-43B0-4B5C-851A-0717208F7C66Q44435430-9F2154D9-7B66-440A-AA40-03450A751C18Q48174299-4509BC2C-064F-42B5-8D03-C8C222C404B5
P2860
Treatment with N-acetyl-seryl-aspartyl-lysyl-proline prevents experimental autoimmune myocarditis in rats
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Treatment with N-acetyl-seryl- ...... autoimmune myocarditis in rats
@ast
Treatment with N-acetyl-seryl- ...... autoimmune myocarditis in rats
@en
type
label
Treatment with N-acetyl-seryl- ...... autoimmune myocarditis in rats
@ast
Treatment with N-acetyl-seryl- ...... autoimmune myocarditis in rats
@en
prefLabel
Treatment with N-acetyl-seryl- ...... autoimmune myocarditis in rats
@ast
Treatment with N-acetyl-seryl- ...... autoimmune myocarditis in rats
@en
P2093
P2860
P1476
Treatment with N-acetyl-seryl- ...... autoimmune myocarditis in rats
@en
P2093
Derek Smolarek
Ed L Peterson
Germán E González
Kevin R Bobbitt
Nour-Eddine Rhaleb
Oscar A Carretero
Pablo Nakagawa
Tang-Dong Liao
Xiao-Ping Yang
P2860
P304
P356
10.1152/AJPHEART.00300.2011
P577
2012-08-24T00:00:00Z